- Home
- ARVN vs HAFC Comparison
ARVN vs HAFC Comparison
Compare ARVN & HAFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARVN | HAFC |
|---|---|---|
| Founded | 2015 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 758.9M |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ARVN | HAFC |
|---|---|---|
| Price | $13.48 | $28.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 23 | 3 |
| Target Price | $18.14 | ★ $31.33 |
| AVG Volume (30 Days) | ★ 753.9K | 300.0K |
| Earning Date | 02-11-2026 | 01-27-2026 |
| Dividend Yield | N/A | ★ 4.01% |
| EPS Growth | N/A | ★ 22.44 |
| EPS | N/A | ★ 2.51 |
| Revenue | ★ $312,300,000.00 | $255,726,000.00 |
| Revenue This Year | $10.55 | $19.44 |
| Revenue Next Year | N/A | $7.64 |
| P/E Ratio | ★ N/A | $11.14 |
| Revenue Growth | ★ 93.86 | 11.21 |
| 52 Week Low | $5.90 | $19.25 |
| 52 Week High | $20.38 | $30.20 |
Technical Indicators
Market Signals| Indicator | ARVN | HAFC |
|---|---|---|
| Relative Strength Index (RSI) | 57.38 | 54.20 |
| Support Level | $12.88 | $24.54 |
| Resistance Level | $14.14 | $28.49 |
| Average True Range (ATR) | 0.70 | 1.09 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 67.89 | 68.67 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About HAFC Hanmi Financial Corporation
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.